摘要
乙型肝炎肝硬化是在乙型肝炎病毒长期感染的基础之上,肝组织出现弥漫性质的纤维化、结节、假小叶等主要特点的一种慢性肝脏疾病。患者在患上乙型肝炎肝硬化之后,很容易出现其它多种并发症,这会给患者的身体健康与生活质量带来严重不良影响。因此,针对乙型肝炎肝硬化抗病毒治疗进行分析研究,可以为该病的临床治疗提供科学参考,对延长患者生命也有积极意义。
The hepatitis B cirrhosis is a kind of chronic liver disease whose main features are diffuse fibrosis, nodules and pseudolobuli in liver tissues on the basis of long-term infection of hepatitis B virus, and the patients are susceptible to other complications, thus bringing severe serious effects on the health and quality of life of patients, therefore,the analysis and research of anti-virus treatment of hepatitis B cirrhosis can provide scientific reference for the clinical treatment and it is of positive significance to prolonging the life of patients.
出处
《系统医学》
2017年第16期160-161,165,共3页
Systems Medicine
关键词
乙型肝炎
肝硬化
抗病毒治疗
研究
进展
Hepatitis B
Cirrhosis
Anti-virus therapy
Research
Development
